(Q38210224)

English

A nomogram to estimate the proportion of patients at hemoglobin A1c target <7% with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials with 39,845 patients

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

0 references

A nomogram to estimate the proportion of patients at hemoglobin A1c target <7% with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials with 39,845 patients (English)

1 reference

Europe PubMed Central

31 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

31 August 2017

Antonio Ceriello

3

1 reference

Europe PubMed Central

31 August 2017

Dario Giugliano

object named as

Dario Giugliano

4

0 references

author name string

Katherine Esposito

1

1 reference

Europe PubMed Central

31 August 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

31 August 2017

Acta Diabetologica

1 reference

Europe PubMed Central

31 August 2017

51

1 reference

Europe PubMed Central

31 August 2017

2

1 reference

Europe PubMed Central

31 August 2017

305-311

1 reference

Europe PubMed Central

31 August 2017

https://scigraph.springernature.com/pub.10.1007/s00592-012-0370-9

0 references

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Advanced methods in meta-analysis: multivariate approach and meta-regression.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Controlling the risk of spurious findings from meta-regression.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

National trends in treatment of type 2 diabetes mellitus, 1994-2007

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0370-9

21 January 2018

Identifiers

10.1007/S00592-012-0370-9

1 reference

Europe PubMed Central

31 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38210224&oldid=1747352572"